Seattle Gummy Company Announces Dr. Michael Jensen As Medical Advisor

December 16 16:30 2021
Dr. Jensen is a metabolic syndrome specialist who focuses on obesity, diabetes, and cardiovascular disease.

Hailing from Mayo Clinic, Dr. Michael Jensen is joining the Seattle Gummy Company (SGC) as a medical advisor. Dr. Jenson, who currently holds the Thomas J. Watson, Jr. Professorship in Honor of Dr. Robert L. Frye at the Mayo Clinic Alix School of Medicine, received his training in Internal Medicine, Endocrinology, and Clinical Nutrition from the Mayo Clinic School of Graduate Medical Education. 

Dr. Jensen’s clinical work focuses on obesity, diabetes, and nutrition support, and his research at the Mayo Clinic focuses on how obesity affects metabolic health. Dr. Jensen received a MERIT award from NIH for his work in these areas and he has been funded for over 30 consecutive years. Dr. Jensen received the TOPS research achievement award from The Obesity Society in 2010.

SGC is on the cutting edge of medical science with its research and development focus on gummy medicine. Dr. Jensen will be advising Seattle Gummy on their gummy medicine research and development including upcoming clinical trials. He will also be offering his expertise on the gummy medicine pipeline as well as the FDA regulatory process.

“We are thrilled to have Dr. Jensen to advise us on clinical matters relating to gummy medicine development.” Said Dr. Connie Wan, SGC’s Founder/CEO, “We started SGC several years ago with the goal to gummimize the common medications.  Did you know that 1 in 6 adults reported having trouble swallowing according to an epidemiology study in 2019?” Continued Dr. Wan, “Gummy as a medicine delivery form will not only make it easier for kids to take medications.  A huge population will benefit from gummy medicine, which, I believe, will be instrumental in increasing treatment efficiency and medication compliance while reducing medication waste.”

SGC has received its first Investigation New Drug (IND) approval from the FDA on its allergy gummy medicine and is working on its second IND approval.  The company’s R&D pipeline has consisted of most of the common OTC medications as well as prescription medications focusing on cardiology, endocrinology, immunology and neurology.

About the Company:

Seattle Gummy Company is a science-based and performance-driven company that takes immense pride in providing a range of innovative chewable gummy formulations. These gummies were developed by their in-house Ph.D. research scientists who have designed their gummies to give the best health benefits at an affordable price. Their wide selection of products, each made with premium, high-quality ingredients, are vegan, non-GMO, all-natural, and made in the USA. They combine Traditional Chinese Medicine with the latest science to ensure all products provide the maximum results for every customer. 

Media Contact
Company Name: Seattle Gummy Company
Contact Person: Brad Fitch
Email: Send Email
Phone: +12062570464
Address:108 1st Ave S
City: Seattle
State: WA 98104
Country: United States
Website: https://seattlegummy.com/

view more articles

About Article Author